RecruitingNCT01510067
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Sponsor
University of Pennsylvania
Enrollment
700 participants
Start Date
Dec 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with cutaneous lupus erythematosus (cle). The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01510067
Related Trials
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT0733248113 locations
Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study
NCT0744053727 locations
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
NCT074555782 locations
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
NCT0726087727 locations
Research Accelerated by You Lupus Registry
NCT069272191 location